HTGM Htg Molecular Diagnostics Inc

HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.

$4.81
As of 04/14/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  05/06/2015
Outstanding shares:  6,214,400
Average volume:  141,317
Market cap:   $29,704,832
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    40434H203
ISIN:        US40434H2031
Sedol:      BMWC5C4
Valuation   (See tab for details)
PE ratio:   -1.42
PB ratio:   2.50
PS ratio:   3.47
Return on equity:   -144.08%
Net income %:   -244.13%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy